Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Although less than 12% of current research funding in the life sciences derives from industry, we are witnessing the growth of a multimillion dollar academic-industrial alliance, a venture that brings significant benefit—and misgivings.
New assay technologies have combined with advances in automation, miniaturization, and affordable computing power to put small molecule drug discovery within reach of biotechnology companies
